Document is current

Article History

Accepted: 25 September 2024

First Online: 7 October 2024

Declarations

:

: Isam Alobid is a member of the Editorial Board and Joaquim Mullol is a Section Editor of Current Allergy and Asthma Reports. They were not involved in assigning this manuscript to Associate Editors or peer reviewers and are separated and blinded from the editorial system from submission inception to decision.Isam Alobid has received honoraria for consultancy and conferences from Viatris, Roche, Sanofi, GSK, MSD, AstraZeneca, Storz, Olympus, Metronic, CINFA, Menarini, Salvat, and Novartis. Miguel Armengot-Carceller has received honoraria for consultancy and conferences from GSK. Mayte Pinilla Urraca has received honoraria for consultancy and conferences from Sanofi, GSK, AstraZeneca, and Italfarmaco. Juan Maza-Solano has received honoraria for consultancy and conferences from GSK, Sanofi, AstraZeneca, and Teva. Isabel González-Guijarro has received honoraria for consultancy and conferences from GSK and Schwabe Farma. Sebastián Umbria Jiménez has received honoraria for consultancy and conferences from GSK. Pilar San Miguel Fraile has received honoraria for consultancy and conferences from GSK and AstraZeneca. Joaquim Mullol has received research grants from AstraZeneca, Genentech, GSK, Viatris, Novartis, Regeneron, Sanofi-Genzyme, and Noucor/Uriach Group, consulting fees from Noucor/Uriach Group and Sanofi-Genzyme, and attended speaker bureaus and/or advisory boards for AstraZeneca, Genentech, GSK, Glenmark, Lilly, Menarini, Mitsubishi-Tanabe Pharma, MSD, Noucor/Uriach Group, Novartis, Proctor & Gamble, Regeneron Pharmaceuticals Inc., Sanofi Genzyme, UCB Pharma, and Viatris.

: This article does not contain any studies with human or animal subjects performed by any of the authors.